UniProt ID | RHG19_HUMAN | |
---|---|---|
UniProt AC | Q14CB8 | |
Protein Name | Rho GTPase-activating protein 19 | |
Gene Name | ARHGAP19 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 494 | |
Subcellular Localization | Nucleus . | |
Protein Description | GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state.. | |
Protein Sequence | MATEAQSEGEVPARESGRSDAICSFVICNDSSLRGQPIIFNPDFFVEKLRHEKPEIFTELVVSNITRLIDLPGTELAQLMGEVDLKLPGGAGPASGFFRSLMSLKRKEKGVIFGSPLTEEGIAQIYQLIEYLHKNLRVEGLFRVPGNSVRQQILRDALNNGTDIDLESGEFHSNDVATLLKMFLGELPEPLLTHKHFNAHLKIADLMQFDDKGNKTNIPDKDRQIEALQLLFLILPPPNRNLLKLLLDLLYQTAKKQDKNKMSAYNLALMFAPHVLWPKNVTANDLQENITKLNSGMAFMIKHSQKLFKAPAYIRECARLHYLGSRTQASKDDLDLIASCHTKSFQLAKSQKRNRVDSCPHQEETQHHTEEALRELFQHVHDMPESAKKKQLIRQFNKQSLTQTPGREPSTSQVQKRARSRSFSGLIKRKVLGNQMMSEKKKKNPTPESVAIGELKGTSKENRNLLFSGSPAVTMTPTRLKWSEGKKEGKKGFL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MATEAQSEG ------CCCCCCCCC | 17.72 | 19413330 | |
7 | Phosphorylation | -MATEAQSEGEVPAR -CCCCCCCCCCCCCC | 55.40 | 29255136 | |
31 | Phosphorylation | SFVICNDSSLRGQPI EEEEECCHHHCCCCE | 19.79 | - | |
48 | Ubiquitination | NPDFFVEKLRHEKPE CCHHHHHHHHCCCCH | 45.58 | - | |
48 (in isoform 2) | Ubiquitination | - | 45.58 | - | |
95 | Phosphorylation | PGGAGPASGFFRSLM CCCCCCHHHHHHHHH | 38.99 | 28555341 | |
96 | Ubiquitination | GGAGPASGFFRSLMS CCCCCHHHHHHHHHH | 28.02 | 29967540 | |
103 | Phosphorylation | GFFRSLMSLKRKEKG HHHHHHHHCCHHCCC | 35.71 | 23186163 | |
105 | Ubiquitination | FRSLMSLKRKEKGVI HHHHHHCCHHCCCEE | 54.86 | 29967540 | |
105 (in isoform 2) | Ubiquitination | - | 54.86 | - | |
186 | Ubiquitination | LLKMFLGELPEPLLT HHHHHHCCCCCCHHC | 64.40 | 29967540 | |
193 | Ubiquitination | ELPEPLLTHKHFNAH CCCCCHHCCCHHCCH | 36.24 | 29967540 | |
195 (in isoform 2) | Ubiquitination | - | 44.66 | - | |
195 | Ubiquitination | PEPLLTHKHFNAHLK CCCHHCCCHHCCHHH | 44.66 | 29967540 | |
202 | Ubiquitination | KHFNAHLKIADLMQF CHHCCHHHHHHHCCC | 26.44 | 29967540 | |
203 | Ubiquitination | HFNAHLKIADLMQFD HHCCHHHHHHHCCCC | 4.54 | 29967540 | |
207 | Sulfoxidation | HLKIADLMQFDDKGN HHHHHHHCCCCCCCC | 3.72 | 21406390 | |
212 | Ubiquitination | DLMQFDDKGNKTNIP HHCCCCCCCCCCCCC | 67.25 | 29967540 | |
251 | Phosphorylation | KLLLDLLYQTAKKQD HHHHHHHHHHHHHCC | 15.89 | 26270265 | |
253 | Phosphorylation | LLDLLYQTAKKQDKN HHHHHHHHHHHCCCC | 27.21 | 26270265 | |
302 | Acetylation | SGMAFMIKHSQKLFK HHHCHHHHHCHHHHH | 25.97 | 7672323 | |
309 | Ubiquitination | KHSQKLFKAPAYIRE HHCHHHHHCCHHHHH | 64.99 | - | |
309 (in isoform 2) | Ubiquitination | - | 64.99 | - | |
314 | Ubiquitination | LFKAPAYIRECARLH HHHCCHHHHHHHHHH | 3.04 | 29967540 | |
320 | Ubiquitination | YIRECARLHYLGSRT HHHHHHHHHHCCCCC | 1.33 | 29967540 | |
322 | Phosphorylation | RECARLHYLGSRTQA HHHHHHHHCCCCCCC | 19.83 | - | |
325 | Phosphorylation | ARLHYLGSRTQASKD HHHHHCCCCCCCCHH | 29.56 | - | |
327 (in isoform 7) | Phosphorylation | - | 30.13 | 22210691 | |
331 (in isoform 2) | Ubiquitination | - | 59.27 | - | |
331 | Ubiquitination | GSRTQASKDDLDLIA CCCCCCCHHHHHHHH | 59.27 | - | |
334 | Ubiquitination | TQASKDDLDLIASCH CCCCHHHHHHHHHHC | 9.17 | 29967540 | |
340 | Ubiquitination | DLDLIASCHTKSFQL HHHHHHHHCHHHHHH | 3.32 | 29967540 | |
343 | Ubiquitination | LIASCHTKSFQLAKS HHHHHCHHHHHHHHH | 26.13 | 29967540 | |
344 | Phosphorylation | IASCHTKSFQLAKSQ HHHHCHHHHHHHHHH | 21.27 | - | |
349 (in isoform 2) | Ubiquitination | - | 63.11 | - | |
349 | Ubiquitination | TKSFQLAKSQKRNRV HHHHHHHHHHHHCCC | 63.11 | 29967540 | |
350 | Phosphorylation | KSFQLAKSQKRNRVD HHHHHHHHHHHCCCC | 35.01 | - | |
358 | Phosphorylation | QKRNRVDSCPHQEET HHHCCCCCCCCHHHH | 27.05 | 29978859 | |
359 | Ubiquitination | KRNRVDSCPHQEETQ HHCCCCCCCCHHHHH | 2.78 | 29967540 | |
365 | Phosphorylation | SCPHQEETQHHTEEA CCCCHHHHHHCHHHH | 32.24 | 29978859 | |
369 | Phosphorylation | QEETQHHTEEALREL HHHHHHCHHHHHHHH | 33.14 | 29978859 | |
369 | Ubiquitination | QEETQHHTEEALREL HHHHHHCHHHHHHHH | 33.14 | 29967540 | |
379 | Ubiquitination | ALRELFQHVHDMPES HHHHHHHHHHHCCHH | 16.14 | 29967540 | |
386 | Phosphorylation | HVHDMPESAKKKQLI HHHHCCHHHHHHHHH | 39.25 | 27050516 | |
387 | Ubiquitination | VHDMPESAKKKQLIR HHHCCHHHHHHHHHH | 26.48 | 29967540 | |
388 | Ubiquitination | HDMPESAKKKQLIRQ HHCCHHHHHHHHHHH | 70.55 | 29967540 | |
389 | Ubiquitination | DMPESAKKKQLIRQF HCCHHHHHHHHHHHH | 45.53 | 29967540 | |
390 (in isoform 2) | Ubiquitination | - | 50.02 | - | |
398 | Ubiquitination | QLIRQFNKQSLTQTP HHHHHHHHHCCCCCC | 42.42 | 29967540 | |
400 | Phosphorylation | IRQFNKQSLTQTPGR HHHHHHHCCCCCCCC | 34.69 | 28450419 | |
401 | Ubiquitination | RQFNKQSLTQTPGRE HHHHHHCCCCCCCCC | 3.69 | 29967540 | |
402 | Phosphorylation | QFNKQSLTQTPGREP HHHHHCCCCCCCCCC | 35.33 | 28450419 | |
404 | Phosphorylation | NKQSLTQTPGREPST HHHCCCCCCCCCCCH | 23.60 | 28450419 | |
407 | Ubiquitination | SLTQTPGREPSTSQV CCCCCCCCCCCHHHH | 54.58 | 29967540 | |
411 | Ubiquitination | TPGREPSTSQVQKRA CCCCCCCHHHHHHHH | 33.62 | 30230243 | |
412 | Phosphorylation | PGREPSTSQVQKRAR CCCCCCHHHHHHHHH | 32.46 | 28450419 | |
416 | Ubiquitination | PSTSQVQKRARSRSF CCHHHHHHHHHHCCC | 49.52 | 29967540 | |
420 | Phosphorylation | QVQKRARSRSFSGLI HHHHHHHHCCCHHHH | 31.15 | 25159151 | |
421 | Ubiquitination | VQKRARSRSFSGLIK HHHHHHHCCCHHHHH | 35.85 | 29967540 | |
422 | Phosphorylation | QKRARSRSFSGLIKR HHHHHHCCCHHHHHH | 25.63 | 30266825 | |
424 | Phosphorylation | RARSRSFSGLIKRKV HHHHCCCHHHHHHHH | 33.66 | 23401153 | |
427 | Ubiquitination | SRSFSGLIKRKVLGN HCCCHHHHHHHHHHH | 4.65 | 29967540 | |
428 | Ubiquitination | RSFSGLIKRKVLGNQ CCCHHHHHHHHHHHH | 51.73 | - | |
430 | Ubiquitination | FSGLIKRKVLGNQMM CHHHHHHHHHHHHHH | 36.49 | 29967540 | |
431 | Ubiquitination | SGLIKRKVLGNQMMS HHHHHHHHHHHHHHC | 10.85 | 30230243 | |
438 | Phosphorylation | VLGNQMMSEKKKKNP HHHHHHHCCHHCCCC | 40.70 | 23401153 | |
440 | Ubiquitination | GNQMMSEKKKKNPTP HHHHHCCHHCCCCCC | 63.69 | 30230243 | |
446 | Phosphorylation | EKKKKNPTPESVAIG CHHCCCCCCCHHHHH | 49.43 | 21815630 | |
447 | Ubiquitination | KKKKNPTPESVAIGE HHCCCCCCCHHHHHC | 32.87 | 29967540 | |
449 | Phosphorylation | KKNPTPESVAIGELK CCCCCCCHHHHHCCC | 20.32 | 29396449 | |
456 | Ubiquitination | SVAIGELKGTSKENR HHHHHCCCCCCCCCC | 56.70 | 29967540 | |
468 | Phosphorylation | ENRNLLFSGSPAVTM CCCCCEECCCCCEEE | 38.03 | 22199227 | |
470 | Phosphorylation | RNLLFSGSPAVTMTP CCCEECCCCCEEECC | 14.42 | 25159151 | |
474 | Phosphorylation | FSGSPAVTMTPTRLK ECCCCCEEECCCEEC | 19.89 | 21712546 | |
475 | Sulfoxidation | SGSPAVTMTPTRLKW CCCCCEEECCCEECC | 3.21 | 21406390 | |
476 | Phosphorylation | GSPAVTMTPTRLKWS CCCCEEECCCEECCC | 16.49 | 25159151 | |
478 | Phosphorylation | PAVTMTPTRLKWSEG CCEEECCCEECCCCC | 39.19 | 21712546 | |
506 (in isoform 2) | Phosphorylation | - | 24114839 | ||
510 (in isoform 2) | Phosphorylation | - | 26552605 | ||
511 (in isoform 2) | Phosphorylation | - | 24114839 | ||
512 (in isoform 2) | Phosphorylation | - | 24114839 | ||
517 (in isoform 2) | Phosphorylation | - | 24114839 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RHG19_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RHG19_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
FHIT_HUMAN | FHIT | physical | 28514442 | |
DCA16_HUMAN | DCAF16 | physical | 28514442 | |
RNF41_HUMAN | RNF41 | physical | 28514442 | |
TDRKH_HUMAN | TDRKH | physical | 28514442 | |
LRP2_HUMAN | LRP2 | physical | 28514442 | |
ERBIN_HUMAN | ERBB2IP | physical | 28514442 | |
CBY1_HUMAN | CBY1 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-470 AND THR-478, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-422, AND MASSSPECTROMETRY. |